{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T08:06:11Z","timestamp":1791446771006,"version":"4.3.3"},"reference-count":116,"publisher":"Elsevier BV","issue":"14","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,11]],"date-time":"2018-04-11T00:00:00Z","timestamp":1523404800000},"content-version":"vor","delay-in-days":375,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","onlinejacc.org","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.jacc.2017.01.047","type":"journal-article","created":{"date-parts":[[2017,4,3]],"date-time":"2017-04-03T14:57:07Z","timestamp":1491231427000},"page":"1842-1860","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":125,"title":["Management of Ventricular Arrhythmias in\u00a0Patients With Advanced Heart Failure"],"prefix":"10.1016","volume":"69","author":[{"given":"Pasquale","family":"Santangeli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Eduardo","family":"Rame","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edo Y.","family":"Birati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis E.","family":"Marchlinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2017.01.047_bib1","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.01.047_bib2","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1161\/CIRCULATIONAHA.115.017545","article-title":"Evidence for intramyocardial disruption of lipid metabolism and increased myocardial ketone utilization in advanced human heart failure","volume":"133","author":"Bedi","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.01.047_bib3","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1161\/CIRCULATIONAHA.112.108316","article-title":"Chronic heart failure: a reversible metabolic syndrome?","volume":"125","author":"Rame","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.01.047_bib4","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.cardfail.2015.04.013","article-title":"Advanced (stage D) heart failure: a statement from the Heart Failure Society of America Guidelines Committee","volume":"21","author":"Fang","year":"2015","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.jacc.2017.01.047_bib5","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1161\/CIRCULATIONAHA.106.642892","article-title":"Predictors of sudden cardiac death and appropriate shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) trial","volume":"114","author":"Saxon","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.01.047_bib6","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1056\/NEJMoa032423","article-title":"Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure","volume":"350","author":"Bristow","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2017.01.047_bib7","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1056\/NEJMoa050496","article-title":"The effect of cardiac resynchronization on morbidity and mortality in heart failure","volume":"352","author":"Cleland","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2017.01.047_bib8","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.healun.2015.10.003","article-title":"Seventh INTERMACS annual report: 15,000 patients and counting","volume":"34","author":"Kirklin","year":"2015","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.jacc.2017.01.047_bib9","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S0002-9149(03)00722-7","article-title":"Relations among heart failure severity, left ventricular loading conditions, and repolarization length in advanced heart failure secondary to ischemic or idiopathic dilated cardiomyopathy","volume":"92","author":"Boccalandro","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2017.01.047_bib10","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1093\/europace\/eus152","article-title":"Independent predictors of mortality in patients with advanced heart failure treated by cardiac resynchronization therapy","volume":"14","author":"Kreuz","year":"2012","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2017.01.047_bib11","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1002\/ejhf.152","article-title":"Super-responders to cardiac resynchronization therapy remain at risk for ventricular arrhythmias and benefit from defibrillator treatment","volume":"16","author":"van der Heijden","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2017.01.047_bib12","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1016\/j.jacc.2013.04.020","article-title":"Ventricular arrhythmias and implantable cardioverter-defibrillator therapy in patients with continuous-flow left ventricular assist devices: need for primary prevention?","volume":"61","author":"Garan","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.01.047_bib13","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/00001573-200005000-00014","article-title":"Molecular aspects of arrhythmias associated with cardiomyopathies","volume":"15","author":"Tomaselli","year":"2000","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.jacc.2017.01.047_bib14","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1111\/j.1540-8167.1999.tb00197.x","article-title":"Cell coupling and impulse propagation in the failing heart","volume":"10","author":"De Mello","year":"1999","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2017.01.047_bib15","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1093\/europace\/euq283","article-title":"An impaired renal function and advanced heart failure represent independent predictors of the incidence of malignant ventricular arrhythmias in patients with an implantable cardioverter\/defibrillator for primary prevention","volume":"12","author":"Kreuz","year":"2010","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2017.01.047_bib16","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1111\/j.1540-8159.2011.03059.x","article-title":"An impaired renal function: a predictor of ventricular arrhythmias and mortality in patients with nonischemic cardiomyopathy and heart failure","volume":"34","author":"Kreuz","year":"2011","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.jacc.2017.01.047_bib17","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00059-015-4398-9","article-title":"LV mechanical dispersion as a predictor of ventricular arrhythmia in patients with advanced systolic heart failure: a pilot study","volume":"41","author":"Banasik","year":"2016","journal-title":"Herz"},{"key":"10.1016\/j.jacc.2017.01.047_bib18","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1161\/CIRCULATIONAHA.105.549659","article-title":"Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy","volume":"112","author":"Nazarian","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.01.047_bib19","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1540-8159.2008.02238.x","article-title":"The characteristics and distribution of the scar tissue predict ventricular tachycardia in patients with advanced heart failure","volume":"32","author":"Yokokawa","year":"2009","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.jacc.2017.01.047_bib20","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2017.01.047_bib21","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jacc.2005.04.038","article-title":"Eplerenone reduces mortality 30 days after randomization following acute myocardial infarction in patients with left ventricular systolic dysfunction and heart failure","volume":"46","author":"Pitt","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.01.047_bib22","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure","volume":"341","author":"Pitt","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2017.01.047_bib23","first-page":"59","article-title":"Reduction of complex ventricular arrhythmias after enalapril treatment in patients with advanced stable heart failure","volume":"21","author":"Pomini","year":"1991","journal-title":"G\u00a0Ital Cardiol"},{"key":"10.1016\/j.jacc.2017.01.047_bib24","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/eurheartj\/ehi579","article-title":"Effects of biventricular pacing on interstitial remodelling, tumor necrosis factor-alpha expression, and apoptotic death in failing human myocardium","volume":"27","author":"D'Ascia","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2017.01.047_bib25","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.jacc.2005.09.016","article-title":"Mode of death in advanced heart failure: the Comparison of Medical, Pacing, and Defibrillation Therapies in Heart Failure (COMPANION) trial","volume":"46","author":"Carson","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.01.047_bib26","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1016\/j.jacc.2010.12.041","article-title":"Reverse remodeling and the risk of ventricular tachyarrhythmias in the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy)","volume":"57","author":"Barsheshet","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.01.047_bib27","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1161\/CIRCULATIONAHA.109.933960","article-title":"Reversal of severe heart failure with a continuous-flow left ventricular assist device and pharmacological therapy: a prospective study","volume":"123","author":"Birks","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.01.047_bib28","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1056\/NEJMoa053063","article-title":"Left ventricular assist device and drug therapy for the reversal of heart failure","volume":"355","author":"Birks","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2017.01.047_bib29","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1056\/NEJMoa0909938","article-title":"Advanced heart failure treated with continuous-flow left ventricular assist device","volume":"361","author":"Slaughter","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2017.01.047_bib30","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/j.healun.2015.05.018","article-title":"Early post-operative ventricular arrhythmias in patients with continuous-flow left ventricular assist devices","volume":"34","author":"Garan","year":"2015","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.jacc.2017.01.047_bib31","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1161\/CIRCEP.114.002394","article-title":"Characteristics of ventricular tachycardia ablation in patients with continuous flow left ventricular assist devices","volume":"8","author":"Sacher","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacc.2017.01.047_bib32","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/j.jacc.2013.04.083","article-title":"Survival after shock therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator recipients according to rhythm shocked. The ALTITUDE survival by rhythm study","volume":"62","author":"Powell","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.01.047_bib33","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jacc.2015.11.017","article-title":"Metabolic Staging in human heart failure: circulating acylcarnitines and the failing heart's energetic signature","volume":"67","author":"Rame","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.01.047_bib34","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1056\/NEJMra063052","article-title":"The failing heart\u2014an engine out of fuel","volume":"356","author":"Neubauer","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2017.01.047_bib35","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/j.hrthm.2016.03.004","article-title":"Comparative effectiveness of antiarrhythmic drugs and catheter ablation for the prevention of recurrent ventricular tachycardia in patients with implantable cardioverter-defibrillators: a systematic review and meta-analysis of randomized controlled trials","volume":"13","author":"Santangeli","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2017.01.047_bib36","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/0735-1097(92)90003-6","article-title":"Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation","volume":"20","author":"Flaker","year":"1992","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.01.047_bib37","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/S0735-1097(96)00358-0","article-title":"Improving survival for patients with atrial fibrillation and advanced heart failure","volume":"28","author":"Stevenson","year":"1996","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.01.047_bib38","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1093\/oxfordjournals.eurheartj.a062178","article-title":"Negative inotropic effect of class-I-antiarrhythmic drugs: comparison of flecainide with disopyramide and quinidine","volume":"8","author":"Hoffmeister","year":"1987","journal-title":"Eur Heart J"},{"issue":"Suppl 6","key":"10.1016\/j.jacc.2017.01.047_bib39","first-page":"S48","article-title":"Combination of antiarrhythmic drugs","volume":"17","author":"L\u00fcderitz","year":"1991","journal-title":"J\u00a0Cardiovasc Pharmacol"},{"key":"10.1016\/j.jacc.2017.01.047_bib40","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/oxfordjournals.eurheartj.a060042","article-title":"Cardiodepressant effects of mexiletine in patients with severe left ventricular dysfunction","volume":"13","author":"Gottlieb","year":"1992","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2017.01.047_bib41","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/jama.295.2.165","article-title":"Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial","volume":"295","author":"Connolly","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2017.01.047_bib42","doi-asserted-by":"crossref","first-page":"3646","DOI":"10.1161\/01.CIR.0000149240.98971.A8","article-title":"Placebo-controlled, randomized clinical trial of azimilide for prevention of ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillator","volume":"110","author":"Dorian","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.01.047_bib43","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1056\/NEJM199906173402402","article-title":"Prevention of implantable-defibrillator shocks by treatment with sotalol","volume":"340","author":"Pacifico","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2017.01.047_bib44","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jacc.2003.07.033","article-title":"Azimilide decreases recurrent ventricular tachyarrhythmias in patients with implantable cardioverter defibrillators","volume":"43","author":"Singer","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.01.047_bib45","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1517\/14740338.2012.660915","article-title":"Examining the safety of amiodarone","volume":"11","author":"Santangeli","year":"2012","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.jacc.2017.01.047_bib46","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1161\/CIRCULATIONAHA.109.853689","article-title":"Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the Sudden Cardiac Death in Heart Failure trial","volume":"120","author":"Packer","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.01.047_bib47","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/j.jacc.2011.07.036","article-title":"Cardiovascular outcomes in the AFFIRM trial (Atrial Fibrillation Follow-Up Investigation of Rhythm Management). An assessment of individual antiarrhythmic drug therapies compared with rate control with propensity score-matched analyses","volume":"58","author":"Saksena","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.01.047_bib48","doi-asserted-by":"crossref","first-page":"44A","DOI":"10.1016\/0002-9149(93)90024-7","article-title":"Clinical safety profile of sotalol in the treatment of arrhythmias","volume":"72","author":"MacNeil","year":"1993","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2017.01.047_bib49","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/clpt.1986.141","article-title":"Character of adverse effects of prophylactic lidocaine in the coronary care unit","volume":"40","author":"Rademaker","year":"1986","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jacc.2017.01.047_bib50","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehw230","article-title":"Randomized comparison of intravenous procainamide vs. intravenous amiodarone for the acute treatment of tolerated wide QRS tachycardia: the PROCAMIO study","author":"Ortiz","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2017.01.047_bib51","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1056\/NEJMoa065457","article-title":"Prophylactic catheter ablation for the prevention of defibrillator therapy","volume":"357","author":"Reddy","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2017.01.047_bib52","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.ccep.2011.08.014","article-title":"Primary ablation for ventricular tachycardia: when and how?","volume":"3","author":"Santangeli","year":"2011","journal-title":"Card Electrophysiol Clin"},{"key":"10.1016\/j.jacc.2017.01.047_bib53","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1513614","article-title":"Ventricular tachycardia ablation versus escalation of antiarrhythmic drugs","volume":"375","author":"Sapp","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2017.01.047_bib54","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.jacc.2009.03.065","article-title":"Long-term follow-up of idiopathic ventricular fibrillation ablation: a multicenter study","volume":"54","author":"Knecht","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.01.047_bib55","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1111\/j.1540-8167.2011.02127.x","article-title":"Imaging of scar in patients with ventricular arrhythmias of right ventricular origin: cardiac magnetic resonance versus electroanatomic mapping","volume":"22","author":"Santangeli","year":"2011","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2017.01.047_bib56","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1161\/CIRCEP.111.967893","article-title":"Correlation between signal-averaged ECG and the histologic evaluation of the myocardial substrate in right ventricular outflow tract arrhythmias","volume":"5","author":"Santangeli","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacc.2017.01.047_bib57","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1161\/CIRCEP.113.000467","article-title":"Epicardial ablation of ventricular tachycardia in ischemic heart disease","volume":"6","author":"Sarkozy","year":"2013","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacc.2017.01.047_bib58","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1161\/CIRCEP.114.001568","article-title":"Catheter ablation of ventricular arrhythmia in nonischemic cardiomyopathy: anteroseptal versus inferolateral scar sub-types","volume":"7","author":"Oloriz","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacc.2017.01.047_bib59","doi-asserted-by":"crossref","first-page":"e004333","DOI":"10.1161\/CIRCEP.116.004333","article-title":"Long-term outcomes of catheter ablation of ventricular tachycardia in patients with cardiac sarcoidosis","volume":"9","author":"Muser","year":"2016","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacc.2017.01.047_bib60","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1161\/CIRCEP.114.002155","article-title":"Acute hemodynamic decompensation during catheter ablation of scar-related ventricular tachycardia: incidence, predictors, and impact on mortality","volume":"8","author":"Santangeli","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacc.2017.01.047_bib61","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s10840-016-0168-8","article-title":"Outcomes of pre-emptive and rescue use of percutaneous left ventricular assist device in patients with structural heart disease undergoing catheter ablation of ventricular tachycardia","volume":"48","author":"Mathuria","year":"2017","journal-title":"J\u00a0Interv Card Electrophysiol"},{"key":"10.1016\/j.jacc.2017.01.047_bib62","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1161\/CIRCEP.112.975888","article-title":"Percutaneous hemodynamic support with Impella 2.5 during scar-related ventricular tachycardia ablation (PERMIT 1)","volume":"6","author":"Miller","year":"2013","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacc.2017.01.047_bib63","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.jacc.2011.06.022","article-title":"Activation and entrainment mapping of hemodynamically unstable ventricular tachycardia using a percutaneous left ventricular assist device","volume":"58","author":"Miller","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.01.047_bib64","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.hrthm.2014.10.004","article-title":"Catheter ablation of scar-based ventricular tachycardia: relationship of procedure duration to outcomes and hospital mortality","volume":"12","author":"Yu","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2017.01.047_bib65","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.hrthm.2014.04.018","article-title":"Procedural and clinical outcomes after catheter ablation of unstable ventricular tachycardia supported by a percutaneous left ventricular assist device","volume":"11","author":"Aryana","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2017.01.047_bib66","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1016\/j.ijcard.2013.06.035","article-title":"Catheter ablation of hemodynamically unstable ventricular tachycardia with mechanical circulatory support","volume":"168","author":"Lu","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2017.01.047_bib67","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1161\/CIRCEP.113.000548","article-title":"Percutaneous left ventricular assist devices in ventricular tachycardia ablation: multicenter experience","volume":"7","author":"Reddy","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacc.2017.01.047_bib68","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1161\/CIRCEP.112.973123","article-title":"Direct comparison of percutaneous circulatory support systems in specific hemodynamic conditions in a porcine model","volume":"5","author":"Ostadal","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacc.2017.01.047_bib69","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1161\/CIRCEP.113.000089","article-title":"Outcome of ventricular tachycardia ablation in patients with nonischemic cardiomyopathy: the impact of noninducibility","volume":"6","author":"Piers","year":"2013","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacc.2017.01.047_bib70","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1016\/j.jacc.2015.02.058","article-title":"Predictive value of programmed ventricular stimulation after catheter ablation of post-infarction ventricular tachycardia","volume":"65","author":"Yokokawa","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.01.047_bib71","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jacc.2012.03.044","article-title":"Endo-epicardial homogenization of the scar versus limited substrate ablation for the treatment of electrical storms in patients with ischemic cardiomyopathy","volume":"60","author":"Di Biase","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.01.047_bib72","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1161\/CIRCULATIONAHA.111.043216","article-title":"Elimination of local abnormal ventricular activities: a new end point for substrate modification in patients with scar-related ventricular tachycardia","volume":"125","author":"Ja\u00efs","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.01.047_bib73","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/j.1540-8167.2011.02246.x","article-title":"Late potentials abolition as an additional technique for reduction of arrhythmia recurrence in scar related ventricular tachycardia ablation","volume":"23","author":"Vergara","year":"2012","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2017.01.047_bib74","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1161\/CIRCEP.110.960740","article-title":"Combined endocardial and epicardial catheter ablation in arrhythmogenic right ventricular dysplasia incorporating scar dechanneling technique","volume":"5","author":"Berruezo","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacc.2017.01.047_bib75","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1161\/01.CIR.101.11.1288","article-title":"Linear ablation lesions for control of unmappable ventricular tachycardia in patients with ischemic and nonischemic cardiomyopathy","volume":"101","author":"Marchlinski","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.01.047_bib76","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1161\/CIRCEP.114.002310","article-title":"Core isolation of critical arrhythmia elements for treatment of multiple scar-based ventricular tachycardias","volume":"8","author":"Tzou","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacc.2017.01.047_bib77","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.hrthm.2015.09.023","article-title":"Substrate mapping for unstable ventricular tachycardia","volume":"13","author":"Santangeli","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2017.01.047_bib78","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1161\/CIRCEP.114.001585","article-title":"End points for ablation of scar-related ventricular tachycardia","volume":"7","author":"Santangeli","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacc.2017.01.047_bib79","doi-asserted-by":"crossref","first-page":"e004328","DOI":"10.1161\/CIRCEP.116.004328","article-title":"Long-term outcome after catheter ablation of ventricular tachycardia in patients with nonischemic dilated cardiomyopathy","volume":"9","author":"Muser","year":"2016","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacc.2017.01.047_bib80","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/jce.13117","article-title":"Beyond the storm: comparison of clinical factors, arrhythmogenic substrate, and catheter ablation outcomes in structural heart disease patients with versus those without a history of ventricular tachycardia storm","volume":"28","author":"Kumar","year":"2017","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2017.01.047_bib81","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/j.hrthm.2016.07.001","article-title":"Long-term outcomes after catheter ablation of ventricular tachycardia in patients with and without structural heart disease","volume":"13","author":"Kumar","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2017.01.047_bib82","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.jacc.2015.11.041","article-title":"Long-term success of irrigated radiofrequency catheter ablation of sustained ventricular tachycardia: post-approval THERMOCOOL VT trial","volume":"67","author":"Marchlinski","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.01.047_bib83","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1016\/j.hrthm.2015.05.036","article-title":"Freedom from recurrent ventricular tachycardia after catheter ablation is associated with improved survival in patients with structural heart disease: an International VT Ablation Center Collaborative Group study","volume":"12","author":"Tung","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2017.01.047_bib84","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1161\/01.CIR.69.4.790","article-title":"Autonomic mechanisms in ventricular fibrillation induced by myocardial ischemia during exercise in dogs with healed myocardial infarction. An experimental preparation for sudden cardiac death","volume":"69","author":"Schwartz","year":"1984","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.01.047_bib85","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1161\/01.CIR.96.10.3450","article-title":"Arterial baroreflex modulation of heart rate in chronic heart failure: clinical and hemodynamic correlates and prognostic implications","volume":"96","author":"Mortara","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.01.047_bib86","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.hrthm.2013.11.028","article-title":"Cardiac sympathetic denervation in patients with refractory ventricular arrhythmias or electrical storm: intermediate and long-term follow-up","volume":"11","author":"Vaseghi","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2017.01.047_bib87","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.tcm.2014.05.006","article-title":"Renal denervation for refractory ventricular arrhythmias","volume":"24","author":"Bradfield","year":"2014","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.jacc.2017.01.047_bib88","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1161\/CIRCULATIONAHA.109.929703","article-title":"Neuraxial modulation for refractory ventricular arrhythmias: value of thoracic epidural anesthesia and surgical left cardiac sympathetic denervation","volume":"121","author":"Bourke","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.01.047_bib89","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.hrthm.2013.12.038","article-title":"Safety and efficacy of renal denervation as a novel treatment of ventricular tachycardia storm in patients with cardiomyopathy","volume":"11","author":"Remo","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2017.01.047_bib90","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.healun.2006.06.008","article-title":"Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates\u20142006","volume":"25","author":"Mehra","year":"2006","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.jacc.2017.01.047_bib91","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/HCO.0b013e32835fb7dc","article-title":"Management of ventricular arrhythmias in patients with ventricular assist devices","volume":"28","author":"Pedrotty","year":"2013","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.jacc.2017.01.047_bib92","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.healun.2010.02.001","article-title":"Implantable cardioverter-defibrillator shocks in patients with a left ventricular assist device","volume":"29","author":"Ambardekar","year":"2010","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.jacc.2017.01.047_bib93","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.amjcard.2006.11.051","article-title":"Ventricular arrhythmias during left ventricular assist device support","volume":"99","author":"Bedi","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2017.01.047_bib94","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.healun.2014.12.007","article-title":"Ventricular assist device thrombosis: a wide spectrum of clinical presentation","volume":"34","author":"Birati","year":"2015","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.jacc.2017.01.047_bib95","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/jce.12839","article-title":"Safety and feasibility of open chest epicardial mapping and ablation of ventricular tachycardia during the period of left ventricular assist device implantation","volume":"27","author":"Patel","year":"2016","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2017.01.047_bib96","doi-asserted-by":"crossref","first-page":"e233","DOI":"10.1093\/ejcts\/ezt347","article-title":"Single-centre experience of 85 patients with a continuous-flow left ventricular assist device: clinical practice and outcome after extended support","volume":"44","author":"Lok","year":"2013","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jacc.2017.01.047_bib97","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1111\/j.1540-8159.2008.01173.x","article-title":"Ventricular arrhythmias after left ventricular assist device implantation","volume":"31","author":"Refaat","year":"2008","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.jacc.2017.01.047_bib98","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.healun.2009.03.011","article-title":"Incidence of ventricular arrhythmias in patients on long-term support with a continuous-flow assist device (HeartMate II)","volume":"28","author":"Andersen","year":"2009","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.jacc.2017.01.047_bib99","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ahj.2012.06.018","article-title":"Epidemiology, management, and outcomes of sustained ventricular arrhythmias after continuous-flow left ventricular assist device implantation","volume":"164","author":"Raasch","year":"2012","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2017.01.047_bib100","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.hrthm.2007.05.029","article-title":"Endocardial catheter ablation of ventricular tachycardia in patients with ventricular assist devices","volume":"4","author":"Dandamudi","year":"2007","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2017.01.047_bib101","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.hrthm.2010.04.033","article-title":"HRS Expert Consensus Statement on the Management of Cardiovascular Implantable Electronic Devices (CIEDs) in patients nearing end of life or requesting withdrawal of therapy","volume":"7","author":"Lampert","year":"2010","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2017.01.047_bib102","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.jacc.2009.04.052","article-title":"Efficacy of antiarrhythmic drugs in arrhythmogenic right ventricular cardiomyopathy: a report from the North American ARVC Registry","volume":"54","author":"Marcus","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.01.047_bib103","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.CIR.94.5.983","article-title":"Arrhythmogenic right ventricular cardiomyopathy. Dysplasia, dystrophy, or myocarditis?","volume":"94","author":"Basso","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.01.047_bib104","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1161\/CIRCULATIONAHA.108.834903","article-title":"Epicardial substrate and outcome with epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy\/dysplasia","volume":"120","author":"Garcia","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.01.047_bib105","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1161\/CIRCEP.111.963066","article-title":"Ablation of ventricular arrhythmias in arrhythmogenic right\u00a0ventricular dysplasia\/cardiomyopathy: arrhythmia-free survival after endo-epicardial substrate based mapping and ablation","volume":"4","author":"Bai","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacc.2017.01.047_bib106","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1161\/CIRCEP.111.968677","article-title":"Outcomes of catheter ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia\/cardiomyopathy","volume":"5","author":"Philips","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacc.2017.01.047_bib107","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1161\/CIRCEP.115.003562","article-title":"Long-term outcome with catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular cardiomyopathy","volume":"8","author":"Santangeli","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacc.2017.01.047_bib108","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1540-8167.2011.02223.x","article-title":"Risk of mortality for ventricular arrhythmia in ambulatory LVAD patients","volume":"23","author":"Brenyo","year":"2012","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2017.01.047_bib109","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.hrthm.2009.12.022","article-title":"Improved survival among ventricular assist device recipients with a concomitant implantable cardioverter-defibrillator","volume":"7","author":"Cantillon","year":"2010","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2017.01.047_bib110","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/eurjhf\/hfq048","article-title":"Implantable defibrillator therapy for ventricular tachyarrhythmia in left ventricular assist device patients","volume":"12","author":"Oswald","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2017.01.047_bib111","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/j.jacc.2005.01.035","article-title":"Effects of left ventricular assist device therapy on ventricular arrhythmias","volume":"45","author":"Ziv","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.01.047_bib112","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0735-1097(98)00521-X","article-title":"Suppression of sustained ventricular tachyarrhythmias: a comparison of d,l-sotalol with no antiarrhythmic drug treatment","volume":"33","author":"K\u00fchlkamp","year":"1999","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.01.047_bib113","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1046\/j.1460-9592.2002.01571.x","article-title":"Efficacy of metoprolol and sotalol in the prevention of recurrences of sustained ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillator","volume":"25","author":"Kettering","year":"2002","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.jacc.2017.01.047_bib114","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1161\/CIRCULATIONAHA.111.072561","article-title":"Efficacy and safety of celivarone, with amiodarone as calibrator, in patients with an implantable cardioverter-defibrillator for prevention of implantable cardioverter-defibrillator interventions or death: the ALPHEE study","volume":"124","author":"Kowey","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.01.047_bib115","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s00059-009-3289-3","article-title":"Percutaneous cardiopulmonary support for catheter ablation of unstable ventricular arrhythmias in high-risk patients","volume":"34","author":"Carbucicchio","year":"2009","journal-title":"Herz"},{"key":"10.1016\/j.jacc.2017.01.047_bib116","doi-asserted-by":"crossref","first-page":"e004492","DOI":"10.1161\/CIRCEP.116.004492","article-title":"Extracorporeal membrane oxygenation for hemodynamic support of ventricular tachycardia ablation","volume":"9","author":"Baratto","year":"2016","journal-title":"Circ Arrhythm Electrophysiol"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109717305107?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109717305107?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T11:12:28Z","timestamp":1568977948000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109717305107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":116,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S0735109717305107"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2017.01.047","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of Ventricular Arrhythmias in\u00a0Patients With Advanced Heart Failure","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2017.01.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}